Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 3

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
The magnetic nanoparticles with the core diameter 10 nm stabilized by sodium oleate and bovine serum albumin in phosphate buffer have been modified by different biocompatible substances such as poly(ethylene glycol) (PEG), dextran (DEX), and polyvinylpyrrolidone (PVP). Prepared biocompatible magnetic fluids were characterized to obtain the particle size distribution using scanning electron microscopy and the dynamic light scattering method. To study the elimination of different modified magnetic nanoparticles from bloodstream, the biocompatible samples were applied intravenously to the mice bloodstream with further blood specimens collecting in given time intervals. Magnetic moment of the lyophilized blood samples was measured by SQUID magnetometer. Time dependence of magnetic moment of magnetic nanoparticles and magnetic nanoparticles modified by DEX, PEG and PVP normalized to the Fe₃O₄ showed that the circulation time of magnetic nanoparticles in the bloodstream depends on the substance used for modification. The unmodified magnetic nanoparticles were trapped by reticuloendothelial system within 1 h while magnetic nanoparticles modified by DEX, PEG and PVP circulated in blood up to 3 h.
2
81%
EN
The magnetic nanoparticles with core diameter 10 nm were modified by poly-L-lysine to bind antibody for cancer cell detection. Prepared biocompatible magnetic fluid (MFPLL) was characterized by dynamic light scattering method to obtain the particle size distribution. The microstructure of the MNPs and MFPLL samples were studied by transmission electron microscopy, X-ray diffraction and Mössbauer spectroscopy. Magnetic properties of the samples were measured by SQUID magnetometer and superparamagnetic behaviour of the samples was confirmed.
EN
The aim of the study was to establish whether there is a significant change in the MRI contrast of magnetite nanoparticles, after BSA protein binding on the surface of particles. The rationale is the applicability of this feature in clinical practice for the tracking of specific proteins which are often associated with various pathologies. Contrast agents could bind to this specific marker, with the change in MRI contrast indicating the presence of pathology. We found that changes in relative contrast acquired at low-field MRI offer potential for the differentiation of magnetite nanoparticles with and without BSA protein. However, the variations in the transverse relaxation time (T₂) and transverse relaxivity (r₂), acquired at high-field MRI, were too small to be applicable for biomedical applications.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.